DarioHealth Corp.
DarioHealth Corp. (DRIO) Stock Overview
Explore DarioHealth Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
60.8M
P/E Ratio
-13.33
EPS (TTM)
$-10.57
ROE
-0.48%
DRIO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of DarioHealth Corp. (DRIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 36.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.56.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -13.33 and a market capitalization of 60.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.